@anabolic_arc's muscle vs glycogen claims, fact-checked
Quick answer
The creator distinguishes between therapeutic testosterone replacement (75-150mg per week targeting physiologic reference ranges) and supraphysiologic cycling (300mg per week), which is a clinically valid distinction. TRT in diagnosed hypogonadal men produces gradual lean mass improvements over months, not weeks, alongside metabolic and mood benefits that precede visible body composition changes. Any testosterone protocol should be supervised by a licensed prescriber with baseline and follow-up labs including hematocrit, lipid panel, and PSA where applicable.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @anabolic_arc actually say?
The creator looked at Alex Eubank's one-month TRT transformation and was unimpressed. Their core argument: "there's basically no fucking difference between these two shots," and that TRT is hormone replacement, not a performance drug. They also drew a line between legitimate TRT (75-150mg of testosterone per week) and what they called "a full-blown fucking cycle" at 300mg per week. That distinction is actually the most useful thing in this video.
They also claimed that natural testosterone levels "will not be stabilized" and fluctuate daily, contrasting that with the steady-state levels you get on exogenous testosterone. They acknowledged some muscle growth benefit on TRT if diet and training are dialed in, and told viewers to get bloodwork and monitor side effects. So far, mostly reasonable. But some of the framing needs a closer look.
Does the science back this up?
The core claim, that TRT is not a physique transformation drug for eugonadal men, is well-supported. The harder question is whether someone with clinically low testosterone sees dramatic one-month changes. They largely do not, at least not in muscle tissue.
A 2013 meta-analysis by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that testosterone therapy in hypogonadal men produces meaningful lean mass gains, but these accumulate over months to years, not weeks. One month is enough to restore libido, mood, and energy, but visible hypertrophy? Unlikely. The creator is right that lighting and water retention (glycogen and intramuscular fluid, not glycogen specifically, but close enough) account for a lot of "before and after" optics. A 2001 study by Phillips in the American Journal of Clinical Nutrition showed that glycogen supercompensation alone can meaningfully alter muscle volume and appearance without new contractile tissue.
On testosterone level stability, they are broadly correct. Endogenous testosterone follows a diurnal rhythm and is sensitive to sleep, stress, and acute illness. Exogenous testosterone cypionate or enanthate, the long-ester forms commonly prescribed, does produce more stable serum levels between injections compared to the natural cycle, though trough levels still dip before the next injection.
What did they get wrong (or right)?
They got the big picture right: TRT is replacement therapy, not a performance-enhancing cycle, and 300mg per week of testosterone is not TRT by any clinical definition. That is a supraphysiologic dose and the distinction matters legally, medically, and physiologically.
Where the nuance slips: the creator conflates glycogen with general water retention. Glycogen storage does increase muscle volume, but the more relevant mechanism in someone starting testosterone is intramuscular fluid retention and increased nitrogen retention, not glycogen specifically. It is a minor but real inaccuracy.
They also say "if you're not a hyper-responder to gear" you will not see dramatic changes. The concept of hyper-responders is real, but it is poorly defined in peer-reviewed literature and the creator presents it as settled science. A 2012 study by Bamman et al. in the Journal of Applied Physiology documented high versus low responders to resistance training, but applying that framework directly to exogenous testosterone response is a stretch without stronger data behind it.
Credit where it is due: pushing viewers to get bloodwork, establish a proper protocol, and understand what they are actually taking is genuinely responsible advice that a lot of fitness creators skip entirely.
What should you actually know?
If you are considering TRT, the starting point is a diagnosis, not a dosing protocol from a TikTok comment section. Hypogonadism is defined clinically, typically as total testosterone below 300 ng/dL on two morning measurements, combined with symptoms. Without that baseline, you are not doing TRT, you are cycling testosterone and suppressing your own production.
One month on legitimate TRT will not produce a dramatic body composition shift. Research consistently shows that lean mass changes from testosterone therapy peak around 6 to 12 months. What you may notice sooner are improvements in energy, mood, sexual function, and recovery quality. Those are real and clinically meaningful, but they photograph poorly compared to a lighting change.
The 300mg per week threshold the creator mentions is not arbitrary. At supraphysiologic doses, the risk profile changes substantially: erythrocytosis, dyslipidemia, cardiovascular strain, and testicular atrophy become more pronounced concerns. Any dose decision should be made with a licensed prescriber reviewing your labs, not based on what someone runs in a YouTube transformation challenge.
Bottom line verdict
This video is more right than wrong, which is not something you can say about most TRT content on TikTok. The creator correctly identifies that TRT is replacement therapy, that one-month transformations are mostly aesthetic illusions, and that 300mg per week is not TRT. The glycogen explanation is imprecise, and the hyper-responder claim is softer science than presented. But the underlying message, know what you are taking, get your labs, understand the dose, is sound. That earns partial credit.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @anabolic_arc's muscle vs glycogen claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
@anabolic_arc's muscle vs glycogen claims, fact-checked should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
Compare available products and select the relevant treatment page for its specific next step.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator distinguishes between therapeutic testosterone replacement (75-150mg per week targeting physiologic reference ranges) and supraphysiologic cycling (300mg per week), which is a clinically valid distinction.
FormBlends verdict
The creator distinguishes between therapeutic testosterone replacement (75-150mg per week targeting physiologic reference ranges) and supraphysiologic cycling (300mg per week), which is a clinically valid distinction. TRT in diagnosed hypogonadal men produces gradual lean mass improvements over months, not weeks, alongside metabolic and mood benefits that precede visible body composition changes. Any testosterone protocol should be supervised by a licensed prescriber with baseline and follow-up labs including hematocrit, lipid panel, and PSA where applicable.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator distinguishes between therapeutic testosterone replacement (75-150mg per week targeting physiologic reference ranges) and supraphysiologic cycling (300mg per week), which is a clinically valid distinction. TRT in diagnosed hypogonadal men produces gradual lean mass improvements over months, not weeks, alongside metabolic and mood benefits that precede visible body composition changes. Any testosterone protocol should be supervised by a licensed prescriber with baseline and follow-up labs including hematocrit, lipid panel, and PSA where applicable.
- One month on TRT is not enough time to build significant muscle tissue; Bhasin et al. (2013, JCEM) show lean mass gains from testosterone therapy accumulate over 6-12 months, not weeks.
- Lighting, hydration status, and intramuscular fluid retention account for the majority of visual differences in short-term before-and-after photos.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- One month on TRT is not enough time to build significant muscle tissue; Bhasin et al. (2013, JCEM) show lean mass gains from testosterone therapy accumulate over 6-12 months, not weeks.
- Lighting, hydration status, and intramuscular fluid retention account for the majority of visual differences in short-term before-and-after photos.
- Clinical TRT targets serum testosterone within the physiologic reference range (roughly 300-1000 ng/dL total testosterone); 300mg per week of exogenous testosterone far exceeds that range.
- Endogenous testosterone fluctuates daily due to diurnal rhythm, sleep quality, stress hormones, and acute illness, making single-point measurements unreliable without context.
- Hypogonadism should be confirmed by two morning total testosterone measurements below 300 ng/dL combined with clinical symptoms before TRT is considered appropriate.
- Supraphysiologic testosterone doses increase risk of erythrocytosis, adverse lipid changes, and cardiovascular strain, risks that are distinct from those at therapeutic replacement doses.
- Bloodwork before starting and at regular intervals during testosterone therapy is not optional; it is the only way to catch hematocrit elevation, hormonal suppression, and metabolic changes before they become serious problems.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
anabolic_arc · TikTok creator
17.6K views on this video
His transformation isn’t that impressive, it’s more so glycogen, not actual muscle tissue. #trending #viral #testosterone #gymrat #fyp #alexeubank
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by anabolic_arc, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.